ModivCare Inc. Net Change in Cash
ModivCare Inc. reported Net Change in Cash of -$21.40 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-12-29.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-12-29
- ModivCare Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $6.80M, a 15.91% decline year-over-year.
- ModivCare Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $8.08M.
- ModivCare Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$1.59M, a 102.61% decline year-over-year.
- ModivCare Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $61.05M, a 47.48% decline year-over-year.
- ModivCare Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $110.33M.
- ModivCare Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$12.19M.
- ModivCare Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$118.45M.
- ModivCare Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$49.93M, a 141.04% decline from fiscal 2020.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | -$21.40M 10-Q · filed 2025-12-29 | ||||
| 2025-06-30 | -$23.34M 10-Q · filed 2025-12-29 | ||||
| 2025-03-31 | $6.80M 10-Q · filed 2025-05-09 | ||||
| 2024-12-31 | $110.33M 10-K · filed 2025-03-06 | ||||
| 2024-09-30 | $46.10M 10-Q · filed 2025-12-29 | ||||
| 2024-06-30 | $8.30M 10-Q · filed 2025-12-29 | ||||
| 2024-03-31 | $8.08M 10-Q · filed 2025-05-09 | ||||
| 2023-12-31 | -$12.19M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | -$6.36M 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | -$7.51M 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | -$1.59M 10-Q · filed 2024-05-03 | ||||
| 2022-12-31 | -$118.45M 10-K · filed 2025-03-06 | ||||
| 2022-09-30 | -$60.69M 10-Q · filed 2023-11-03 | ||||
| 2022-06-30 | -$45.44M 10-Q · filed 2023-08-04 | ||||
| 2022-03-31 | $61.05M 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | -$49.93M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | -$56.66M 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | $107.57M 10-Q · filed 2022-08-08 | ||||
| 2021-03-31 | $116.25M 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | $121.68M 10-K · filed 2023-03-07 | ||||
| 2020-09-30 | $125.14M 10-Q · filed 2021-11-05 | ||||
| 2020-06-30 | -$16.59M 10-Q · filed 2021-08-06 | ||||
| 2020-03-31 | $192.77M 10-Q · filed 2021-05-07 | $192.80M 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $49.31M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $29.35M 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | $22.05M 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | $38.26M 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | -$89.24M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | -$49.36M 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | -$61.64M 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | -$9.51M 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | $15.21M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $12.89M 10-Q · filed 2018-11-08 | ||||
| 2017-06-30 | -$21.89M 10-Q · filed 2018-08-08 | ||||
| 2017-03-31 | $10.03M 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | -$18.43M 10-K · filed 2019-03-01 |